Targeting of human immunodeficiency virus-infected cells by CD8+ T lymphocytes armed with universal T-cell receptors

Blood

Volumn 84, Issue 9, 1994, Pages 2878-2889

  Roberts, Margo R ^a   Qin, Lu ^b   Zhang, Dezhen ^b   Smith, Douglas H ^b   Tran, Annie Chen ^b   Dull, Thomas J ^b   Groopman, Jerome E ^b   Capon, Daniel J ^b   Byrn, Randal A ^b   Finer, Mitchell H ^b  

^a CELL GENESYS INC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

T LYMPHOCYTE RECEPTOR;

ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; ARTICLE; CELLULAR IMMUNITY; EFFECTOR CELL; GENETIC PREDISPOSITION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOTHERAPY; PRIORITY JOURNAL; SUPPRESSOR CELL; TARGET CELL;

EID: 0028079896     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v84.9.2878.2878     Document Type: Article

References (63)

1. Lukacher AE, Braciale VL, Braciale TJ: In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific. J Exp Med 160:814, 1984
2. Taylor PM, Askonas BA: Influenza nucleoprotein-specific cytotoxic T-cell clones are protective in vivo. Immunology 58:417, 1986
3. Reddehase MJ, Weiland F, Munch K, Jonjic S, Luske A, Koszinowski UH: Interstitial murine cytomegalovirus pneumonia after irradiation: Characterization of cells that limit viral replication during established infection of the lungs. J Virol 55:264, 1985
4. Koszinowski UH, Reddehase MJ, Keil GM, Volkmer H, Jonjic S, Messerle M, del Val M, Mutter W, Munch K, Buhler B: Molecular analysis of herpesviral gene products recognized by protective cytolytic T lymphocytes. Immunol Lett 16:185, 1987
5. Riddell SR, Watanabe KS, Goodrich JM, Li CR, Agha ME, Greenberg PD: Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 257:238, 1992
6. Cheynier R, Langlade-Demoyen P, Marescot MR, Blanche S, Blondin G, Wain-Hobson S, Griscelli C, Vilmer E, Plata F: Cytotoxic T lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus-1-infected mothers. Eur J Immunol 22:2211, 1992
7. Rowland-Jones SL, Nixon DF, Aldhous MC, Gotch F, Ariyoshi K, Hallam N. Kroll JS, Froebel K, McMichael A: HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant. Lancet 341:860, 1993
8. Koenig S, Fuerst TR, Wood LV, Woods RM, Suzich JA, Jones GM, de la Cruz VF, Davey RT Jr, Venkatesan S, Moss B: Mapping the fine specificity of a cytolytic T cell response to HIV-1 nef protein. J Immunol 145:127, 1990
9. Walker CM, Moody DJ, Stites DP, Levy JA: CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 234:1563, 1986
10. Culmann B, Gomard E, Kieny MP, Guy B, Dreyfus F, Saimot AG, Sereni, D, Levy JP: An antigenic peptide of the HIV-1 NEF protein recognized by cytotoxic T lymphocytes of seropositive individuals in association with different HLA-B molecules. Eur J Immu-nol 19:2383, 1989
11. Riviere Y, Tanneau-Salvadori F, Regnault A, Lopez O, Sansonetti P, Guy B, Kieny MP, Fournel JJ, Montagnier L: Human immunodeficiency virus-specific cytotoxic responses of seropositive individuals: distinct types of effector cells mediate killing of targets expressing gag and env proteins. J Virol 63:2270, 1989
12. McChesney M, Tanneau F, Regnault A, Sansonetti P, Montagnier L, Kieny MP, Riviere Y: Detection of primary cytotoxic T lymphocytes specific for the envelope glycoprotein of HIV-1 by deletion of the env amino-terminal signal sequence. Eur J Immunol 20:215, 1990
13. Kundu SK, Merigan TC: Inverse relationship of CD8+CD11+ suppressor T cells with human immunodeficiency virus (HIV)-specific cellular cytotoxicity and natural killer cell activity in HIV infection. Immunology 74:567, 1991
14. Joly P, Guillon JM, Mayaud C, Plata F, Theodorou I, Denis M, Debre P, Autran B: Cell-mediated suppression of HIV-specific cytotoxic T lymphocytes. J Immunol 143:2193, 1989
15. Hoffenbach A, Langlade-Demoyen P, Dadaglio G, Vilmer E, Michel F, Mayaud C, Autran B, Plata F: Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans. J Immunol 142:452, 1989
16. Walker BD, Chakrabarti S, Moss B, Paradis TJ, Flynn T, Durno AG, Blumberg RS, Kaplan JC, Hirsch MS, Schooley RT: HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature 328:345, 1987
17. Mackewicz C, Levy JA: CD8+ cell anti-HIV activity: Nonlytic suppression of virus replication. AIDS Res Hum Retroviruses 8:1039, 1992
18. Powell JD, Bednarik DP, Folks TM, Jehuda-Cohen T, Villinger F, Sell KW, Ansari AA: Inhibition of cellular activation of retroviral replication by CD8+ T cells derived from non-human primates. Clin Exp Immunol 91:473, 1993
19. Letourneur F, Klausner RD: T-cell and basophil activation through the cytoplasmic tail of T-cell-receptor zeta family proteins. Proc Natl Acad Sci USA 88:8905, 1991
20. Irving BA, Weiss A: The cytoplasmic domain of the T cell receptor zeta chain is sufficient to couple to receptor-associated signal transduction pathways. Cell 64:891, 1991
21. Romeo C, Seed B: Cellular immunity to HIV activated by CD4 fused to T cell or Fc receptor polypeptides. Cell 64:1037, 1991
22. Romeo C, Amiot M, Seed B: Sequence requirements for induction of cytolysis by the T cell antigen/Fc receptor zeta chain. Cell 68:889, 1992
23. Eshhar Z, Waks T, Gross G, Schindler DG: Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptor. Proc Natl Acad Sci USA 90:720, 1993
24. Rabson AB, Martin MA: Molecular organization of the AIDS retrovirus. Cell 40:477, 1985
25. Allan JS, Coligan JE, Barin F, McLane MF, Sodroski JG, Rosen CA: Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III. Science 228:1091, 1985
26. Veronese FD, DeVico AL, Copeland TD, Oroszlan S, Gallo RC, Sarngadharan MG: Characterization of gp41 as the transmembrane protein coded by the HTLV-III/LAV envelope gene. Science 229:1402, 1985
27. Willey RL, Bonifacino JS, Potts BJ, Martin MA, Klausner RD: Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160. Proc Natl Acad Sci USA 85:9580, 1988
28. Dalgleish AG, Beverley PC, Clapham PR, Crawford DH, Greaves MF, Weiss RA: The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312:763, 1985
29. Klatzmann D, Champagne E, Chamaret S, Gruest J, Guetard D, Hercend T, Gluckman JC, Montagnier L: T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 312:767, 1984
30. Gorny MK, Gianakakos V, Sharpe S, Zolla-Pazner S: Generation of human monoclonal antibodies to human immunodeficiency virus. Proc Natl Acad Sci USA 86:1624, 1989
31. Xu JY, Gorny MK, Palker T, Karwowska S, Zolla-Pazner S: Epitope mapping of two immunodominant domains of gp41, the transmembrane protein of human immunodeficiency virus type 1, using ten human monoclonal antibodies. J Virol 65:4832, 1991
32. Hwu P, Yannelli J, Kriegler M, Anderson WF, Perez C, Chiang Y, Schwarz S, Cowherd R, Delgado C, Mule J, Rosenberg SA: Functional and molecular characterization of tumor-infiltrating lymphocytes transduced with tumor necrosis factor-α cDNA for the gene therapy of cancer in humans. J Immunol 150:4104, 1993a
33. Hwu P, Shafer GE, Treisman J, Schindler DG, Gross G, Cowherd R, Rosenberg SA, Eshhar Z: Lysis of ovarian cancer cells by human lymphocytes redirected with a chimeric gene composed of an antibody variable region and the Fc receptor gamma chain. J Exp Med 178:361, 1993b
34. Orloff DG, Ra CS, Frank SJ, Klausner RD, Kinet JP: Family of disulphide-linked dimers containing the zeta and eta chains of the T-cell receptor and the gamma chain of Fc receptors. Nature 347:189, 1990
35. Zoller MJ, Smith M: Oligonucleotide-directed mutagenesis using M13-derived vectors: an efficient and general procedure for the production of point mutations in any fragment of DNA. Nucleic Acids Res 10:6487, 1982
36. Byrn RA, Mordenti J, Lucas C, Smith D, Marsters SA, Johnson JS, Cossum P, Chamow SM, Wurm FM, Gregory T: Biological properties of a CD4 immunoadhesin. Nature 344:667, 1990
37. Graham FL, Smiley J, Russell WC, Nairn R: Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36:59, 1977
38. Posner MR, Hideshima T, Cannon T, Mukherjee M, Mayer KH, Byrn RA: An IgG human monoclonal antibody that reacts with HIV-1/GP120. inhibits virus binding to cells, and neutralizes infection. J Immunol 146:4325, 1991
39. Finer MH, Dull TJ, Qin L, Farson D, Roberts MR: Kat: A high-efficiency retroviral transduction system for primary human T lymphocytes. Blood 83:43, 1994
40. Matzinger P: The JAM test: a simple assay for DNA fragmentation and cell death. J Immunol Methods 145:185, 1991
41. Weissman AM, Hou D, Orloff DG, Modi WS, Seuanez H, O'Brien SJ, Klausner RD: Molecular cloning and chromosomal localization of the human T-cell receptor zeta chain: Distinction from the molecular CD3 complex. Proc Natl Acad Sci USA 85:9709, 1988
42. Maddon PJ, Molineaux SM, Maddon DE, Zimmerman KA, Godfrey M, Alt FW, Chess L, Axel R: Structure and expression of the human and mouse T4 genes. Proc Natl Acad Sci USA 84:9155, 1987
43. Tyler DS, Stanley SD, Zolla-Pazner S, Gorny MK, Shadduck PP, Langlois AJ, Matthews TJ, Bolognesi DP, Palker TJ, Weinhold KJ: Identification of sites within gp41 that serve as targets for antibody-dependent cellular cytotoxicity by using human monoclonal antibodies. J Immunol 145:3276, 1990
44. Bedzyk WD, Weidner KM, Denzin LK, Johnson LS, Hardman KD, Pantoliano MW, Asel ED, Voss EW Jr: Immunological and structural characterization of high affinity anti-fluorescein single-chain antibody. J Biol Chem 265:18615, 1990
45. Chaudhary VK, Gallo MG, FitzGerald DJ, Pastan I: A recombinant single-chain immunotoxin composed ofanti-Tac variable regions and a truncated diphtheria toxin. Proc Natl Acad Sci USA 87:9491, 1990
46. Weiss A, Imboden JB: Cell surface molecules and early events involved in human T lymphocyte activation. Adv Immunol 41:1, 1987
47. Scott P, Kaufmann SH: The role of T-cell subsets and cytokines in the regulation of infection. Immunol Today 12:346, 1991
48. Sher A, Gazzinelli RT, Oswald IP, Clerici M, Kullberg M, Pearce EJ, Berzofsky JA, Mosmann TR, James SL: Role of T-cell derived cytokines in the downregulation of immune responses in parasitic and retroviral infection. Immunol Rev 127:183, 1992
49. Clerici M, Shearer GM: A TH1 → TH2 switch is a critical step in the etiology of HIV infection. Immunol Today 14:107, 1993
50. Kasid A, Morecki S, Aebersold P, Cornetta K, Culver K, Freeman S, Director E, Lotze MT, Blaese RM, Anderson WF: Human gene transfer: Characterization of human tumor-infiltrating lymphocytes as vehicles for retroviral-mediated gene transfer in man. Proc Natl Acad Sci USA 87:473, 1990
51. Morecki S, Karson E, Cornetta K, Kasid A, Aebersold P, Blaese RM, Anderson WF, Rosenberg SA: Retrovirus-mediated gene transfer into CD4+ and CD8+ human T cell subsets derived from tumor-infiltrating lymphocytes and peripheral blood mononuclear cells. Cancer Immunol Immunother 32:342, 1991
52. Van Beusechem VW, Kukler A, Heidt PJ, Valerio D: Long-term expression of human adenosine deaminase in rhesus monkeys transplanted with retrovirus-infected bone-marrow cells. Proc Natl Acad Sci USA 89:7640, 1992
53. Apperley JF, Luskey BD, Williams DA: Retroviral gene transfer of human adenosine deaminase in murine hematopoietic cells: Effect of selectable marker sequences on long-term expression. Blood 78:310, 1991
54. Emerman M, Temin HM: Genes with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism. Cell 39:449, 1984
55. De Palazzo IG, Gercel-Taylor C, Kitson J, Weiner LM: Potentiation of tumor lysis by a bispecific antibody that binds to CA19-9 antigen and the Fc gamma receptor expressed by human large granular lymphocytes. Cancer Res 50:7123, 1990
56. Howell DN, Andreotti PE, Dawson JR, Cresswell P: Natural killing target antigens as inducers of Interferon: studies with an immunoselected, natural killing-resistant human T lymphoblastoid cell line. J Immunol 134:971, 1985
57. Hsieh-Ma ST, Eaton AM, Shi T, Ring DB: In vitro cytotoxic targeting by human mononuclear cells and bispecific antibody 2B1, recognizing c-erbB-2 protooncogene product and Fc gamma receptor III. Cancer Res 52:6832, 1992
58. Piatak M Jr, Saag MS, Yang LC, Clark SJ, Kappes JC, Luk KC, Hahn BH, Shaw GM, Lifson JD: High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 259:1749, 1993
59. Pantaleo G, Graziosi C, Fauci AS: New concepts in the immunopathogenesis of human immunodeficiency virus infection. N Engl J Med 328:327, 1993
60. Bourinbaiar AS: HIV and gag [letter] Nature 349:111, 1991
61. Lin YL, Askonas BA: Biological properties of an influenza A virus-specific killer T cell clone: inhibition of virus replication in vivo and induction of delayed-type hypersensitivity reactions. J Exp Med 154:225, 1981
62. Klarnet JP, Matis LA, Kern DE, Mizuno MT, Peace DJ, Thompson JA, Greenberg PD, Cheever MA: Antigen-driven T cell clones can proliferate in vivo, eradicate disseminated leukemia, and provide specific immunologic memory. J Immunol 138:4012, 1987
63. Alexander RB, Rosenberg SA: Adoptively transferred tumorinfiltrating lymphocytes can cure established metastatic tumor in mice and persist long-term in vivo as functional memory T lymphocytes. J Immunother 10:389, 1991